NCT02508259View on ClinicalTrials.gov

University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

April 30, 2016

Conditions
Autism Spectrum Disorders
Interventions
DRUG

Suramin

20 mg/kg IV in 50 ml saline over 30 minutes

DRUG

Saline

50 ml IV over 30 minutes

Trial Locations (1)

92093

University of California, San Diego School of Medicine, La Jolla

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT02508259 - University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial | Biotech Hunter | Biotech Hunter